Psychotherapy is a collaborative approach used by psychologists to help people overcome various mental illnesses and emotional difficulties.
This report aims to provide a comprehensive presentation of the global market for Psychotherapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychotherapeutic Drugs. This report contains market size and forecasts of Psychotherapeutic Drugs in global, including the following market information:
Global Psychotherapeutic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Psychotherapeutic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antipsychotic Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Psychotherapeutic Drugs include Eli Lilly, Johnson&Johnson, Pfizer, Bristol-Myers Squibb, Allergan, GlaxoSmithKline, AstraZeneca and Astellas Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Psychotherapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychotherapeutic Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Psychotherapeutic Drugs Market Segment Percentages, by Type, 2022 (%)
Antipsychotic Drugs
Antidepressants
Psychotherapeutic Combinations
Global Psychotherapeutic Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Psychotherapeutic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Psychotherapeutic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Psychotherapeutic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psychotherapeutic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Psychotherapeutic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Johnson&Johnson
Pfizer
Bristol-Myers Squibb
Allergan
GlaxoSmithKline
AstraZeneca
Astellas Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psychotherapeutic Drugs, market overview.
Chapter 2: Global Psychotherapeutic Drugs market size in revenue.
Chapter 3: Detailed analysis of Psychotherapeutic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psychotherapeutic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Psychotherapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychotherapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psychotherapeutic Drugs Overall Market Size
2.1 Global Psychotherapeutic Drugs Market Size: 2022 VS 2030
2.2 Global Psychotherapeutic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Psychotherapeutic Drugs Players in Global Market
3.2 Top Global Psychotherapeutic Drugs Companies Ranked by Revenue
3.3 Global Psychotherapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Psychotherapeutic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Psychotherapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psychotherapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Psychotherapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Psychotherapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Psychotherapeutic Drugs Market Size Markets, 2022 & 2030
4.1.2 Antipsychotic Drugs
4.1.3 Antidepressants
4.1.4 Psychotherapeutic Combinations
4.2 By Type - Global Psychotherapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global Psychotherapeutic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Psychotherapeutic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Psychotherapeutic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psychotherapeutic Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Psychotherapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global Psychotherapeutic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Psychotherapeutic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Psychotherapeutic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Psychotherapeutic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Psychotherapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global Psychotherapeutic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Psychotherapeutic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Psychotherapeutic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Psychotherapeutic Drugs Revenue, 2018-2030
6.3.2 US Psychotherapeutic Drugs Market Size, 2018-2030
6.3.3 Canada Psychotherapeutic Drugs Market Size, 2018-2030
6.3.4 Mexico Psychotherapeutic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Psychotherapeutic Drugs Revenue, 2018-2030
6.4.2 Germany Psychotherapeutic Drugs Market Size, 2018-2030
6.4.3 France Psychotherapeutic Drugs Market Size, 2018-2030
6.4.4 U.K. Psychotherapeutic Drugs Market Size, 2018-2030
6.4.5 Italy Psychotherapeutic Drugs Market Size, 2018-2030
6.4.6 Russia Psychotherapeutic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Psychotherapeutic Drugs Market Size, 2018-2030
6.4.8 Benelux Psychotherapeutic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Psychotherapeutic Drugs Revenue, 2018-2030
6.5.2 China Psychotherapeutic Drugs Market Size, 2018-2030
6.5.3 Japan Psychotherapeutic Drugs Market Size, 2018-2030
6.5.4 South Korea Psychotherapeutic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Psychotherapeutic Drugs Market Size, 2018-2030
6.5.6 India Psychotherapeutic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Psychotherapeutic Drugs Revenue, 2018-2030
6.6.2 Brazil Psychotherapeutic Drugs Market Size, 2018-2030
6.6.3 Argentina Psychotherapeutic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Psychotherapeutic Drugs Revenue, 2018-2030
6.7.2 Turkey Psychotherapeutic Drugs Market Size, 2018-2030
6.7.3 Israel Psychotherapeutic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Psychotherapeutic Drugs Market Size, 2018-2030
6.7.5 UAE Psychotherapeutic Drugs Market Size, 2018-2030
7 Psychotherapeutic Drugs Companies Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Psychotherapeutic Drugs Major Product Offerings
7.1.4 Eli Lilly Psychotherapeutic Drugs Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly Key News & Latest Developments
7.2 Johnson&Johnson
7.2.1 Johnson&Johnson Company Summary
7.2.2 Johnson&Johnson Business Overview
7.2.3 Johnson&Johnson Psychotherapeutic Drugs Major Product Offerings
7.2.4 Johnson&Johnson Psychotherapeutic Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson&Johnson Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Psychotherapeutic Drugs Major Product Offerings
7.3.4 Pfizer Psychotherapeutic Drugs Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Psychotherapeutic Drugs Major Product Offerings
7.4.4 Bristol-Myers Squibb Psychotherapeutic Drugs Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Psychotherapeutic Drugs Major Product Offerings
7.5.4 Allergan Psychotherapeutic Drugs Revenue in Global Market (2018-2023)
7.5.5 Allergan Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Psychotherapeutic Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Psychotherapeutic Drugs Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Psychotherapeutic Drugs Major Product Offerings
7.7.4 AstraZeneca Psychotherapeutic Drugs Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Astellas Pharma
7.8.1 Astellas Pharma Company Summary
7.8.2 Astellas Pharma Business Overview
7.8.3 Astellas Pharma Psychotherapeutic Drugs Major Product Offerings
7.8.4 Astellas Pharma Psychotherapeutic Drugs Revenue in Global Market (2018-2023)
7.8.5 Astellas Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Psychotherapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Psychotherapeutic Drugs Market Drivers in Global Market
Table 3. Psychotherapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Psychotherapeutic Drugs in Global Market
Table 5. Top Psychotherapeutic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Psychotherapeutic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Psychotherapeutic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Psychotherapeutic Drugs Product Type
Table 9. List of Global Tier 1 Psychotherapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Psychotherapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Psychotherapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Psychotherapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Psychotherapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Psychotherapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Psychotherapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Psychotherapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Psychotherapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Psychotherapeutic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Psychotherapeutic Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Psychotherapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Psychotherapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Psychotherapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Psychotherapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Psychotherapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Eli Lilly Company Summary
Table 31. Eli Lilly Psychotherapeutic Drugs Product Offerings
Table 32. Eli Lilly Psychotherapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly Key News & Latest Developments
Table 34. Johnson&Johnson Company Summary
Table 35. Johnson&Johnson Psychotherapeutic Drugs Product Offerings
Table 36. Johnson&Johnson Psychotherapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson&Johnson Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Psychotherapeutic Drugs Product Offerings
Table 40. Pfizer Psychotherapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Psychotherapeutic Drugs Product Offerings
Table 44. Bristol-Myers Squibb Psychotherapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Allergan Company Summary
Table 47. Allergan Psychotherapeutic Drugs Product Offerings
Table 48. Allergan Psychotherapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Allergan Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Psychotherapeutic Drugs Product Offerings
Table 52. GlaxoSmithKline Psychotherapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Psychotherapeutic Drugs Product Offerings
Table 56. AstraZeneca Psychotherapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Astellas Pharma Company Summary
Table 59. Astellas Pharma Psychotherapeutic Drugs Product Offerings
Table 60. Astellas Pharma Psychotherapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Astellas Pharma Key News & Latest Developments
List of Figures
Figure 1. Psychotherapeutic Drugs Segment by Type in 2022
Figure 2. Psychotherapeutic Drugs Segment by Application in 2022
Figure 3. Global Psychotherapeutic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Psychotherapeutic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Psychotherapeutic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Psychotherapeutic Drugs Revenue in 2022
Figure 8. By Type - Global Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Psychotherapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Psychotherapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 16. US Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 28. China Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Psychotherapeutic Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Psychotherapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Eli Lilly Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson&Johnson Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Allergan Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Astellas Pharma Psychotherapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
